JP Morgan Chase
MDCX

JP Morgan Chase’s Medicus Pharma MDCX Stock Holding History

JP Morgan Chase’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
+25,622
New +$9.07K ﹤0.01% 6853

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.5B AUM 19.97% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

JP Morgan Chase's MDCX Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Medicus Pharma (MDCX) in Q2 2026: 25,622 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #6853 among its holdings.

14 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • JP Morgan Chase held 25,622 shares of Medicus Pharma worth $12.5K as of Q2 2026.
  • Medicus Pharma was a new JP Morgan Chase position in Q2 2026.
  • Medicus Pharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6853 holding.
  • 14 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.